News
October 16, 2008 - The one-year follow-up of the FAME study (FFR vs. angiography for multivessel evaluation) was presented at TCT 2008 and confirms the beneficial clinical and economic impact of FFR when used routinely to guide treatments of multi-vessel disease.
October 15, 2008
News
October 15, 2008 – TeraMedica reported that it won the Frost & Sullivan (F&S) 2008 Customer Value Enhancement Award in ...
October 14, 2008News
October 15, 2008 - Boston Scientific Corp. announced estimated U.S. market shares for September for its two drug-eluting ...
October 14, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
October 15, 2008 – Neovasc Inc., a new specialty vascular device company comprised of the former Medical Ventures Corp ...
October 14, 2008News
October 15, 2008 – Two-year results from the ENDEAVOR-IV clinical trial show that the Endeavor drug-eluting stent (DES) ...
October 14, 2008News
October 15, 2008 - Julio Palmaz, M.D. made his mark on the medical world 20 years ago with the invention of the stent ...
October 14, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
October 15, 2008 - Advanced Circulatory Systems Inc. announced this week it has received an additional $1.5 million in ...
October 14, 2008News
October 15, 2008 - The new name and branding for MEDRAD’s interventional products division was unveiled to the public at ...
October 14, 2008News
October 15, 2008 – The latest update to an independently conducted pooled data analysis shows that Medtronic’s Endeavor ...
October 14, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
October 15, 2008 - At TCT 2008, Philips Healthcare is showcasing cath lab improvements, designed to present users with seamless interaction between image acquisition and visualization technologies, hemodynamic monitoring and charting, cath lab and statistical reporting, and multimodality image access, viewing and storage.
October 14, 2008News
October 15, 2008 - Cardiogenesis Corp. sponsored an educational symposium entitled "New Horizons in Cardiac Regenerative Medicine: Advancements in Revascularization & Stem Cell Therapy," this week in conjunction with the TCT meeting in Washington, D.C.
October 14, 2008News
October 15, 2008 – At TCT 2008, Boston Scientific Corp. announced 12-month left main and three-vessel disease subset ...
October 14, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
The Philips cath lab experience provides interaction between image acquisition and visualization technologies, hemodynamic monitoring and charting, cath lab and statistical reporting and multimodality image access, viewing and storage.
October 13, 2008
Technology
October 14, 2008 - St. Jude Medical Inc. said today at TCT 2008 that the FDA and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device.
October 13, 2008News
October 14, 2008 - Edwards Lifesciences Corp. released new data from two studies of the Edwards SAPIEN transcatheter ...
October 13, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now